Evidence map›Paper›PMID 25740631›Full record

ArticleScientific reports2015

Mechanism of action of thalassospiramides, a new class of calpain inhibitors.

Liang Lu, Michael J Meehan, Shuo Gu, Zhilong Chen, Weipeng Zhang, Gen Zhang, Lingli Liu, Xuhui Huang, Pieter C Dorrestein, Ying Xu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Chinese Herbal Medicine Meets Biological Networks of Complex Diseases: A Computational Perspective.Evidence-based complementary and alternative medicine : eCAM · 2017
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Liang LuKAUST Global Collaborative Research, Division of Life Science, School of Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Michael J MeehanSkaggs School of Pharmacy &Pharmaceutical Sciences, University of California at San Diego, La Jolla, California 92037, United States.
Shuo GuDepartment of Chemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Zhilong ChenDepartment of Chemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Weipeng ZhangKAUST Global Collaborative Research, Division of Life Science, School of Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Gen ZhangKAUST Global Collaborative Research, Division of Life Science, School of Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Lingli LiuKAUST Global Collaborative Research, Division of Life Science, School of Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Xuhui HuangDepartment of Chemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Pieter C Dorrestein1] Skaggs School of Pharmacy &Pharmaceutical Sciences, University of California at San Diego, La Jolla, California 92037, United States [2] Department of Pharmacology, University of California at San Diego, La Jolla, California 92037, United States [3] Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California at San Diego, La Jolla, California 92037, United States.
Ying Xu1] KAUST Global Collaborative Research, Division of Life Science, School of Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China [2] School of Life Science, Shenzhen University, Nanhai Ave 3688, Shenzhen, Guangdong Province, 518060, China.
Bradley S Moore1] Skaggs School of Pharmacy &Pharmaceutical Sciences, University of California at San Diego, La Jolla, California 92037, United States [2] Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California at San Diego, La Jolla, California 92037, United States.
Pei-Yuan QianKAUST Global Collaborative Research, Division of Life Science, School of Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Hong Kong University of Science and Technology · HKScripps Institution of Oceanography · USUniversity of Montana · US

Funding

Experiment based genome mining of ribosomal natural productsR01GM097509 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C, MOORE, BRADLEY S · 2012 to 2015
$1.9M
NIGMS NIH HHS GM97509NIGMS NIH HHS R01 GM097509
6 · The paper itself

Abstract

Thalassospiramides comprise a large family of lipopeptide natural products produced by Thalassospira and Tistrella marine bacteria. Here we provide further evidence of their nanomolar inhibitory activity against the human calpain 1 protease. Analysis of structure-activity relationship data supported our hypothesis that the rigid 12-membered ring containing an α,β-unsaturated carbonyl moiety is the pharmacologically active functional group, in contrast to classic electrophilic "warheads" in known calpain inhibitors. Using a combination of chemical modifications, mass spectrometric techniques, site-directed mutagenesis, and molecular modeling, we show the covalent binding of thalassospiramide's α,β-unsaturated carbonyl moiety to the thiol group of calpain's catalytic Cys115 residue by a Michael 1,4-addition reaction. As nanomolar calpain inhibitors with promising selectivity and low toxicity from natural sources are rare, we consider thalassospiramides as promising drug leads.

Indexed as

CalpainChromatography, High Pressure LiquidGlycoproteinsHumansInhibitory Concentration 50Models, MolecularMolecular ConformationPeptides, CyclicProtein BindingSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSpectroscopy, Fourier Transform InfraredCalpaincalpain inhibitorsGlycoproteinsPeptides, Cyclic

Identifiers

PMID25740631
PMCPMC4350077
OpenAlexW1996175386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.